Skip to main content

and
  1. No Access

    Article

    Long-term outcomes in patients with septic shock transfused at a lower versus a higher haemoglobin threshold: the TRISS randomised, multicentre clinical trial

    We assessed the predefined long-term outcomes in patients randomised in the Transfusion Requirements in Septic Shock (TRISS) trial.

    Sofie L. Rygård, Lars B. Holst, Jørn Wetterslev, Per Winkel in Intensive Care Medicine (2016)

  2. No Access

    Article

    Long-term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer’s acetate

    We assessed long-term mortality and hospitalisation in patients with severe sepsis resuscitated with hydroxyethyl starch (HES) or Ringer’s acetate.

    Anders Perner, Nicolai Haase, Per Winkel, Anne B. Guttormsen in Intensive Care Medicine (2014)

  3. Article

    Open Access

    Transfusion requirements in septic shock (TRISS) trial - comparing the effects and safety of liberal versus restrictive red blood cell transfusion in septic shock patients in the ICU: protocol for a randomised controlled trial

    Transfusion of red blood cells (RBC) is recommended in septic shock and the majority of these patients receive RBC transfusion in the intensive care unit (ICU). However, benefit and harm of RBCs have not been ...

    Lars B Holst, Nicolai Haase, Jørn Wetterslev, Jan Wernerman, Anders Åneman in Trials (2013)

  4. No Access

    Chapter

    On the Formation and Fate of Total Plasma Homocysteine

    The total concentration of homocysteine (tHcy)* in plasma is a useful marker of impaired function of cobalamin and folate. Moreover, it is an independent risk factor for atherosclerotic disease [1]. These find...

    Helga Refsum, Anne B. Guttormsen in Homocysteine Metabolism: From Basic Scienc… (1997)